MaxCyte's (MXCT) Outperform Rating Reiterated at William Blair

William Blair reaffirmed their outperform rating on shares of MaxCyte (NASDAQ:MXCT – Free Report) in a report published on Tuesday morning, RTT News reports. Separately, Craig Hallum started coverage on MaxCyte in a research note on Wednesday, November 29th. They issued a buy rating and a $7.00 target price on the stock. View Our Latest […]

Related Keywords

United States ,Canada ,Craig Hallum ,John Joseph Johnston ,William Blair ,Tower Research Capital ,Royal Bank ,Us Bancorp ,Maxcyte Inc ,Financial Services Group Inc ,Free Report ,Director John Joseph Johnston ,Services Group ,Research Capital ,Get Free Report ,Maxcyte Daily ,